FDA Inspection 1158649 — Ira H. Thorla, Jr., MD
The FDA completed an inspection of Ira H. Thorla, Jr., MD on Nov 18, 2021 in Baton Rouge, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 18, 2021
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Baton Rouge, LA (United States)
Additional Details
Clinical Investigator (CI)